(Q51956739)

English

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.

scientific article published in July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

differentiated thyroid carcinoma

1 reference

based on heuristic

inferred from title

author name string

Michael Lassmann

1

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

Heribert Hänscheid

2

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

Carlo Chiesa

3

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

Cecilia Hindorf

4

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

Glenn Flux

5

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

Markus Luster

6

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

EANM Dosimetry Committee

7

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

35

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

7

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

1405-1412

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

https://scigraph.springernature.com/pub.10.1007/s00259-008-0761-x

0 references

Thyroid stunning in vivo and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. II. Bone marrow changes including leukemia]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorbed dose calculations to blood and blood vessels for internally deposited radionuclides

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimization of equipment and methodology for whole body activity retention measurements in children undergoing targeted radionuclide therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18491092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-008-0761-X

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18491092

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51956739&oldid=1506856484"